Modern Africa Today
SEE OTHER BRANDS

Your daily news update on Africa

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on May 27, 2025

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced an upcoming presentation at the …

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the …

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

- Study will assess relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine candidate against an approved mRNA comparator at 12 months - SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) …

Reflect Scientific, Inc. Announces Strategic Cost-Cutting Initiative to Reduce SG&A Expenses by Up to 35% in 2025

Reflect Scientific, Inc. Announces Strategic Cost-Cutting Initiative to Reduce SG&A Expenses by Up to 35% in 2025

OREM, Utah, May 27, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leading innovator in cryogenic cooling technologies, today announced a comprehensive initiative to reduce Selling, General …

Murray Brook Minerals, Puma’s Subsidiary, Closes $220,000 Private Placement

Murray Brook Minerals, Puma’s Subsidiary, Closes $220,000 Private Placement

RIMOUSKI, Quebec, May 27, 2025 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSXV: PUMA) (“Puma”), announces that its subsidiary, Murray Brook Minerals Inc. (“MBM” or “Murray Brooks Minerals”)   has closed a non-brokered offering consisting of 4,400,000 flow- …

ORYZON to Provide Corporate Progress Updates at Several Events in May-June

ORYZON to Provide Corporate Progress Updates at Several Events in May-June

Foro MedCap 2025 BIO International Convention 2025 Discovery and Development Europe 2025 MADRID and CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a …

Domestic Metals Announces Non-Brokered Private Placement and Change of CFO and Corporate Secretary

Domestic Metals Announces Non-Brokered Private Placement and Change of CFO and Corporate Secretary

**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) …

Final Settlement of Computing Power Loss! KixaMiner Launches Intelligent Chain Scheduling System with Millisecond-Level Optimal Mining Protocol Switching

Final Settlement of Computing Power Loss! KixaMiner Launches Intelligent Chain Scheduling System with Millisecond-Level Optimal Mining Protocol Switching

London, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- KixaMiner, a pioneer in global compliant cloud mining, announced a major upgrade to its core technical architecture today – the official launch of the "Intelligent Chain Scheduling System" (ICSS). By …

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

Cash runway extended into 2028; capital proceeds to fund operations through potential 2027 efficacy readout for LX2006 in Friedreich ataxia cardiomyopathy Financing led by Frazier Life Sciences and Janus Henderson Investors with participation from new and …

American Tungsten Corp. Commences Mine Site Preparation and Exploration Work

American Tungsten Corp. Commences Mine Site Preparation and Exploration Work

Vancouver, BC, May 27, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that the Company has commenced construction and building work to support exploration …

ZA Miner Launches New 3-Day Short-Term Cloud Mining Contracts for May 2025 — Built for XRP Holders Seeking Fast Passive Returns

ZA Miner Launches New 3-Day Short-Term Cloud Mining Contracts for May 2025 — Built for XRP Holders Seeking Fast Passive Returns

London, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- ZA Miner, a global leader in crypto cloud mining, today announced the launch of new 3-day short-term cloud mining contracts designed specifically for Ripple (XRP) holders looking to generate fast and …

Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2…

Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2…

CANOPY assessed pemivibart safety and tolerability, antiviral immunobridging, and exploratory efficacy against COVID-19, and is the only clinical trial of an authorized or approved COVID-19 monoclonal antibody or vaccine with placebo-controlled clinical …

BioCryst to Present at Upcoming Investor Conferences

BioCryst to Present at Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Jefferies Global Healthcare Conference in New York on Wednesday, …

Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 46th Annual …

REPEAT – Koryx Copper Announces Further Highly Encouraging Drill Results at the Haib Copper Project, Southern Namibia

REPEAT – Koryx Copper Announces Further Highly Encouraging Drill Results at the Haib Copper Project, Southern Namibia

Highlights     • Completed 29 drill holes out of a planned 37 holes in Phase 2 for 8,647m of diamond drilling.   • Many results received have higher Cu grade than average MRE over large intercepts and include:             • HM62: 572m @ 0.33% Cu (0 to 572m …

 Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise as Leader of Lifecore’s Sales Organization Focused on …

Emerita Achieves 81.5% Gold Recovery for 27% Improvement Over Previous Metallurgical Testing for IBW Project

Emerita Achieves 81.5% Gold Recovery for 27% Improvement Over Previous Metallurgical Testing for IBW Project

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX – V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to provide updated results on its metallurgical testing program (the “Program”) for its wholly-owned Iberian …

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

BOSTON and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or …

TRX Gold Files NI 43-101 Preliminary Economic Assessment for the Buckreef Gold Project

TRX Gold Files NI 43-101 Preliminary Economic Assessment for the Buckreef Gold Project

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- RX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the “Company” or “TRX Gold”) has filed on SEDAR+ a Technical Report prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral …

Volt Lithium Announces Executive Team Appointment, AGM and Proposed Strategic Name Change, Prepares for Future U.S. Transition

Volt Lithium Announces Executive Team Appointment, AGM and Proposed Strategic Name Change, Prepares for Future U.S. Transition

CALGARY, Alberta, May 27, 2025 (GLOBE NEWSWIRE) -- Volt Lithium Corp. (TSXV: VLT | OTCQB: VLTLF | FSE: I2D) (“Volt” or the “Company”) is pleased to announce that Marty Scase, Volt’s co-founder and Board member, has agreed to join the Volt management team …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service